FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to chemical-pharmaceutical industry and represents a drug for treating diseases associated with gallbladder and bile ducts, containing active substances 250–500 mg ursodeoxycholic acid (UDCA) and 200–600 mg of hymecromone, macrogol cetostearate and excipients. Inventions also involve the use of macrogol cetostearate to increase the stability of the drug containing the active substances ursodeoxycholic acid (UDCA), hymecromone and excipients.
EFFECT: group of inventions provides potentiating the effect, improving evacuation of bile, reducing symptoms of congestion, changing qualitative composition of bile and shift from thicker bile to more fluid in relation to diseases associated with gallbladder and bile ducts.
4 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED AGENT CONTAINING UDCA, HYMECROMONE AND SILYMARIN (VERSIONS) | 2017 |
|
RU2738444C2 |
| METHOD OF TREATING PATIENTS SUFFERING FROM FIRST STAGE CHOLELITHIASIS | 2012 |
|
RU2519198C2 |
| METHOD OF PROPHYLAXIS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH CHOLELITHIASIS AFTER LAPAROSCOPIC CHOLECYSTECTOMY | 2017 |
|
RU2657838C1 |
| PHARMACEUTICAL COMPOSITION BASED ON HEPATOPROTECTOR AND PREBIOTIC AND METHOD FOR PRODUCING AND APPLYING THE COMPOSITION | 2006 |
|
RU2318538C1 |
| METHOD FOR BILIARY SLUDGE TREATMENT IN PATIENTS WITH CHRONIC BILIAR-DEPENDENT PANCREATITIS | 2016 |
|
RU2632443C1 |
| METHOD OF PREDICTING THE EFFECTIVENESS OF LITHOLYSIS IN CHOLELITHIASIS IN COMBINATION WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2023 |
|
RU2813033C1 |
| HEPATOPROTECTIVE AND ANTIHEPATOTOXIC PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING HEPATIC DISEASES THAT INVOLVES INTRODUCTION OF SAID COMPOSITION | 2008 |
|
RU2381800C1 |
| METHOD FOR TREATING CHOLELITHIASIS | 1992 |
|
RU2045956C1 |
| METHOD OF TREATING PATIENTS WITH CELIAC WITH CHOLELITHIASIS OF 1ST STAGE IN SETTING OF GALLBLADDER ANOMALY | 2017 |
|
RU2668123C1 |
| METHOD FOR TREATMENT OF DISEASES CAUSED AND ACCOMPANYING DISTURBANCE IN METABOLISM OF BILE ACIDS AND CHOLESTEROL | 2005 |
|
RU2294207C2 |
